chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX261113P00010500
IBRX Nov 13 2026 10.50 Put
optionOPRA

EODOct 12, 2026
1.60USD+39.130%(+0.45)23Vol33OI
Loading…
Underlying
IBRX
Underlying Price
$8.34
Type
Put
Strike
10.5
Expiration
Nov 13, 2026
DTE
24d
Moneyness
ITM
Intrinsic
$2.16
IBRX 10.5 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Oct 23, 20263d$0.89+18.67%1238
Oct 30, 202610d$1.32+7.32%154
Nov 6, 202617d$1.17-29.94%120
Nov 13, 202624d$1.60+39.13%2333
Nov 27, 202638d$1.87+24.67%47
IBRX Nearby Strikes · Nov 13, 2026
StrikeLastChangeVolOpen IntMoneyness
7.5 P$0.28-6.67%107OTM
8 P$0.75+114.29%166OTM
8.5 P$0.45-6.25%527ITM
9 P$0.75+25.00%4238ITM
9.5 P$1.14+26.67%2024ITM
10 P$1.05-12.50%411ITM
10.5 P$1.60+39.13%2333ITM
11 P$1.50+0.00%42ITM
11.5 P$2.02-4.72%15ITM
12 P$2.47+0.00%11ITM
12.5 P——00ITM
13 P——00ITM
13.5 P——00ITM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.